Published in BioCentury Innovations on June 23, 2016 | Tools & Techniques

Graphic illustrating the path of placenta-homing peptides that don't reach the fetus which may shift the risk-reward ratio for drug development in pregnancy. This could give diseases such as preeclampsia and fetal growth restriction better chance at treatment.